Braincheck garners a mindless $1.5 in new capital for its artificial intelligence platform for dementia care. (throw in the obvious comment about demented investors)
Tridiuum puts the u in health care, oh wait there isn't one, for $9 million in new capital for a questionaire about behavioral health, oh wait, maybe that's too simplistic, they are a digital health company with a platform for behavioral health.
Trouble conglomerate General Electric filed an expected IPO to spin off its health unit, which is expected to have a value in the tens of billions of dollars.
ClearDATA (must be something going on that you are supposed to capitalize all the letters in the end of your business name) secures $26 million in new capital for its business to provide security for health information.
Enzyme Health catalyzes growth by gathering in $1.7 million in new financing to support its business of arranging for clinicians to find temporary or on-demand work.
Health iPASS capitalizes on a hot market and gets $10 million in fresh capital to help ensure that burdened patients pay their providers excessive cost-sharing amounts they may owe.
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.